Tianyu Co., Ltd.: Two products are expected to be selected for the twelfth batch of national drug centralized procurement.

Tianyu Co., Ltd. announced that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., participated in the bidding for the twelfth batch of national centralized drug procurement. According to the announcement of the proposed selection results released by the Joint Procurement Office on July 31, 2026, hydrochloride trazodone tablets and tolvaptan tosylate tablets are proposed for selection. The procurement period will be from the date of execution of the selection results until December 31, 2029.